business.financialpost.com
Roche wins FDA approval for immunotherapy cocktail against lung cancer
ZURICH — Roche’s Tecentriq immunotherapy mixed with chemotherapy won U.S. approval as an initial treatment for a form of lung cancer as the Swiss drugmaker seeks to establish its altern…